<?xml version="1.0" encoding="UTF-8"?>
<p>The currently approved drugs used to treat AD are all cholinesterase inhibitors, which only intend to inhibit the activity of cholinesterase enzyme and not seem to modify or improve the cognitive or memory skills declined due to the disease. AD pathogenesis involves several pathophysiological pathways, indicating it to be a multifactorial disease that needs medication which can act on multimode targets involved in several pathways. This strategy of treatment is realistic and can significantly modify the disease progression [
 <xref rid="ref063" ref-type="bibr">63</xref>]. Herbal combination therapy, involving a combination of two or more potent plant extracts in a single dose, can help acquire synergistic effects to reduce the progression of the AD. Such a treatment may also be referred to as a fixed-dose combination. Combinational therapies are not found to be associated with adverse effects as they can overcome toxicity by accessing multi-target mechanisms [
 <xref rid="ref064" ref-type="bibr">64</xref>].
</p>
